These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 23164159

  • 1. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction.
    Rodrigues IA, Stangos AN, McHugh DA, Jackson TL.
    Am J Ophthalmol; 2013 Feb; 155(2):270-276.e2. PubMed ID: 23164159
    [Abstract] [Full Text] [Related]

  • 2. INTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME.
    Day S, Martinez JA, Nixon PA, Levitan M, Dooner JW, Wong RW, Harper CA.
    Retina; 2016 Apr; 36(4):733-7. PubMed ID: 26383712
    [Abstract] [Full Text] [Related]

  • 3. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
    Quezada-Ruiz C, Pieramici DJ, Nasir M, Rabena M, Steinle N, Castellarin AA, Dhoot D, Couvillion S, See RF, Avery RL.
    Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tomographic features and surgical outcomes of vitreomacular traction syndrome.
    Yamada N, Kishi S.
    Am J Ophthalmol; 2005 Jan; 139(1):112-7. PubMed ID: 15652835
    [Abstract] [Full Text] [Related]

  • 6. TREATMENT OF VITREOMACULAR TRACTION WITH INTRAVITREAL PERFLUOROPROPANE (C3F8) INJECTION.
    Steinle NC, Dhoot DS, Quezada Ruiz C, Castellarin AA, Pieramici DJ, See RF, Couvillion SC, Nasir MA, Avery RL.
    Retina; 2017 Apr; 37(4):643-650. PubMed ID: 27681001
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A, Horozoglu F, Celik E, Nohutcu AF.
    Retina; 2007 Jun; 27(5):557-66. PubMed ID: 17558316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitrectomy in vitreomacular traction syndrome evaluated by ocular coherence tomography (OCT) retinal mapping.
    Larsson J.
    Acta Ophthalmol Scand; 2004 Dec; 82(6):691-4. PubMed ID: 15606465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravitreal Injection of Perfluoropropane is More Efficacious than Sulfur Hexafluoride In Releasing Vitreomacular Traction.
    Čokl N, Globočnik Petrovič M.
    Acta Clin Croat; 2018 Jun; 57(2):327-334. PubMed ID: 30431727
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.
    Singh RP, Li A, Bedi R, Srivastava S, Sears JE, Ehlers JP, Schachat AP, Kaiser PK.
    Br J Ophthalmol; 2014 Mar; 98(3):356-60. PubMed ID: 24357495
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R.
    Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
    [Abstract] [Full Text] [Related]

  • 19. Vitreomacular traction as a consequence of posterior hyaloidal contraction after transpupillary thermotherapy.
    Kashani AH, Aaberg TM, Capone A.
    Am J Ophthalmol; 2013 May; 155(5):937-45. PubMed ID: 23352339
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.